UBS Group AG - CORVUS PHARMACEUTICALS INC ownership

CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 46 filers reported holding CORVUS PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
UBS Group AG ownership history of CORVUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$9,782
-36.2%
6,7000.0%0.00%
Q2 2023$15,343
+53.1%
6,700
-39.2%
0.00%
Q1 2023$10,023
+150.9%
11,014
+134.3%
0.00%
Q4 2022$3,995
-77.8%
4,700
-79.3%
0.00%
Q3 2022$18,000
-18.2%
22,656
+0.4%
0.00%
Q2 2022$22,000
-4.3%
22,571
+60.0%
0.00%
Q1 2022$23,000
+4.5%
14,107
+52.2%
0.00%
Q4 2021$22,000
+46.7%
9,270
+209.0%
0.00%
Q3 2021$15,000
+87.5%
3,0000.0%0.00%
Q2 2021$8,000
-11.1%
3,0000.0%0.00%
Q1 2021$9,000
-75.0%
3,000
-70.1%
0.00%
Q4 2020$36,000
+111.8%
10,043
+133.4%
0.00%
Q3 2020$17,000
+750.0%
4,303
+498.5%
0.00%
Q2 2020$2,000
-66.7%
719
-74.5%
0.00%
Q1 2020$6,0002,816
+16464.7%
0.00%
Q2 2019$0
-100.0%
17
-99.7%
0.00%
Q1 2019$22,000
-4.3%
5,525
-13.6%
0.00%
Q4 2018$23,000
+15.0%
6,392
+259.9%
0.00%
Q1 2018$20,000
-79.2%
1,776
-80.9%
0.00%
Q4 2017$96,000
+357.1%
9,307
+599.8%
0.00%
Q3 2017$21,000
+40.0%
1,330
+90.5%
0.00%
Q1 2017$15,000
-21.1%
698
-48.7%
0.00%
Q4 2016$19,000
-5.0%
1,360
-4.2%
0.00%
Q2 2016$20,0001,4190.00%
Other shareholders
CORVUS PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
ADAMS STREET PARTNERS LLC 3,275,616$11,661,0002.42%
Telemetry Investments, L.L.C. 189,081$673,0001.14%
CHI Advisors LLC 490,877$1,748,0000.49%
BVF INC/IL 1,943,712$6,920,0000.27%
Orbimed Advisors 6,767,584$24,093,0000.21%
Novo Holdings A/S 847,906$3,019,0000.13%
Golden Green, Inc. 19,539$70,0000.06%
ALGERT GLOBAL LLC 15,467$55,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 133,700$476,0000.01%
Hikari Power Ltd 19,959$71,0000.01%
View complete list of CORVUS PHARMACEUTICALS INC shareholders